Ad-ERα-36-Fc-GFP的制备及鉴定
作者:
基金项目:

浙江省自然科学基金(LQ19H160017,LY18H160006)


Preparation and characterization of Ad-ERα-36-Fc-GFP
Author:
  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献 [23]
  • |
  • 相似文献 [20]
  • | | |
  • 文章评论
    摘要:

    ERα-36是雌激素受体α新亚型,促进肿瘤细胞增殖、侵袭及耐药,可作为治疗靶点,但目前仅有小分子靶向药物研发。利用重组腺病毒携带诱饵受体,可进行靶向ERα-36的基因治疗探索。首先通过基因工程技术,构建可表达由Igκ信号肽引导分泌的重组融合蛋白ERα-36-Fc的穿梭质粒pDC316-Ig κ-ERα-36-Fc-GFP;利用AdMaxTM腺病毒包装系统进行Ad-ERα-36-Fc-GFP腺病毒的包装、鉴定及扩增;感染三阴性乳腺癌细胞MDA-MB-231并进行表达及功能验证。结果表明成功制备Ad-ERα-36-Fc-GFP重组腺病毒,可高效感染三阴性乳腺癌细胞MDA-MB-231,表达并分泌ERα-36-Fc重组蛋白,显著抑制EGFR/ERK信号通路。Ad-ERα-36-Fc-GFP腺病毒的制备为进一步开展靶向ERα-36的肿瘤基因治疗研究奠定基础。

    Abstract:

    ERα-36 is a novel subtype of estrogen receptor α which promotes tumor cell proliferation,invasion and drug resistance,and it serves as a therapeutic target.However,only small-molecule compounds targeting ERα-36 are under development as anticancer drugs at present.Gene therapy approach targeting ERα-36 can be explored using recombinant adenovirus armed with decoy receptor.The recombinant shuttle plasmid pDC316-Ig κ-ERα-36-Fc-GFP was constructed via genetic engineering to express an Ig κ-signaling peptide-leading secretory recombinant fusion protein ERα-36-Fc.The recombinant adenovirus Ad-ERα-36-Fc-GFP was subsequently packaged,characterized and amplified using AdMaxTM adenovirus packaging system.The expression of fusion protein and functional outcome of Ad-ERα-36-Fc-GFP transduction were further analyzed with triple-negative breast cancer MDA-MB-231 cells.Results showed that the recombinant adenovirus Ad-ERα-36-Fc-GFP was successfully generated.The virus effectively infected MDA-MB-231 cells which resulted in expression and secretion of the recombinant fusion protein ERα-36-Fc,leading to significant inhibition of EGFR/ERK signaling pathway.Preparation of the recombinant adenovirus Ad-ERα-36-Fc-GFP provides a basis for further investigation on cancer gene therapy targeting ERα-36.

    参考文献
    [1] Wang Z, Zhang X, Shen P, et al. Identification, cloning, and expression of human estrogen receptor-alpha36, a novel variant of human estrogen receptor-alpha66. Biochem Biophys Res Commun, 2005, 336(4):1023-1027.
    [2] Mahboobifard F, Dargahi L, Jorjani M, et al. The role of ERα36 in cell type-specific functions of estrogen and cancer development. Pharmacol Res, 2021, 163:105307.
    [3] Wang Z, Zhang X, Shen P, et al. A variant of estrogen receptor-α, hER-α36:transduction of estrogen-and antiestrogen-dependent membrane-initiated mitogenic signaling. PNAS, 2006, 103(24):9063-9068.
    [4] Li GL, Zhang J, Jin KT, et al. Estrogen receptor-α36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cells. Mol Oncol, 2013, 7(3):611-624.
    [5] Takahashi K, Akatsu Y, Podyma-Inoue KA, et al. Targeting all transforming growth factor-β isoforms with an Fc chimeric receptor impairs tumor growth and angiogenesis of oral squamous cell cancer. J Biol Chem, 2020, 295(36):12559-12572.
    [6] Zhang J, Li GL, Li ZQ, et al. Estrogen-independent effects of ER-α36 in ER-negative breast cancer. Steroids, 2012, 77(6):666-673.
    [7] Su XY, Xu X, Li GL, et al. ER-α36:a novel biomarker and potential therapeutic target in breast cancer. Onco Targets Ther, 2014, 7:1525-1533.
    [8] Wang ZY, Yin L. Estrogen receptor alpha-36(ER-α36):a new player in human breast cancer. Mol Cell Endocrinol, 2015, 418:193-206.
    [9] Zhang XT, Kang LG, Ding L, et al. A positive feedback loop of ER-α36/EGFR promotes malignant growth of ER-negative breast cancer cells. Oncogene, 2011, 30(7):770-780.
    [10] Wang Q, Jiang J, Ying G, et al. Tamoxifen enhances stemness and promotes metastasis of ERα36+breast cancer by upregulating ALDH1A1 in cancer cells. Cell Res, 2018, 28(3):336-358.
    [11] Dai YJ, Qiu YB, Jiang R, et al. Concomitant high expression of ERα36, GRP78 and GRP94 is associated with aggressive papillary thyroid cancer behavior. Cell Oncol, 2018, 41(3):269-282.
    [12] You H, Meng K, Wang ZY. The ER-α36/EGFR signaling loop promotes growth of hepatocellular carcinoma cells. Steroids, 2018, 134:78-87.
    [13] Yu L, Das P, Vall AJ, et al. Bisphenol A induces human uterine leiomyoma cell proliferation through membrane-associated ERα36 via nongenomic signaling pathways. Mol Cell Endocrinol, 2019, 484:59-68.
    [14] Wang HB, Li T, Ma DZ, et al. ERα36 gene silencing promotes tau protein phosphorylation, inhibits cell proliferation, and induces apoptosis in human neuroblastoma SH-SY5Y cells. FASEB J, 2018, 32(12):6456-6468.
    [15] Qu C, Ma JY, Zhang YJ, et al. Estrogen receptor variant ER-α36 promotes tamoxifen agonist activity in glioblastoma cells. Cancer Sci, 2019, 110(1):221-234.
    [16] Saunders KO. Conceptual approaches to modulating antibody effector functions and circulation half-life. Front Immunol, 2019, 10:1296.
    [17] Yang C, Gao X, Gong R. Engineering of Fc fragments with optimized physicochemical properties implying improvement of clinical potentials for Fc-based therapeutics. Front Immunol, 2017, 8:1860.
    [18] Nikolic I, Yung LM, Yang P, et al. Bone morphogenetic protein 9 is a mechanistic biomarker of portopulmonary hypertension. Am J Respir Crit Care Med, 2019, 199(7):891-902.
    [19] Tolcher AW, Papadopoulos KP, Patnaik A, et al. A phase Ⅰ, first in human study of FP-1039(GSK3052230), a novel FGF ligand trap, in patients with advanced solid tumors. Ann Oncol, 2016, 27(3):526-532.
    [20] Yung LM, Nikolic I, Paskin-Flerlage SD, et al. A selective transforming growth factor-β ligand trap attenuates pulmonary hypertension. Am J Respir Crit Care Med, 2016, 194(9):1140-1151.
    [21] Zhou B, Zhang H, Su X, et al. Therapeutic effects of a novel BAFF blocker on arthritis. Signal Transduct Target Ther, 2019, 4:19.
    [22] Gooding S, Olechnowicz SWZ, Morris EV, et al. Transcriptomic profiling of the myeloma bone-lining niche reveals BMP signalling inhibition to improve bone disease. Nat Commun, 2019, 10(1):4533.
    [23] Zhou L, Wang HY, Tong SS, et al. Single chain Fc-dimer-human growth hormone fusion protein for improved drug delivery. Biomaterials, 2017, 117:24-31.
    引证文献
    网友评论
    网友评论
    分享到微博
    发 布
引用本文

谢雨琼,李春春,李晓烨,陈丽红,严毛晓,曹江. Ad-ERα-36-Fc-GFP的制备及鉴定[J]. 生物工程学报, 2022, 38(3): 1086-1095

复制
分享
文章指标
  • 点击次数:297
  • 下载次数: 1006
  • HTML阅读次数: 1022
  • 引用次数: 0
历史
  • 收稿日期:2021-07-14
  • 最后修改日期:2021-10-17
  • 在线发布日期: 2022-03-25
文章二维码
您是第5807024位访问者
生物工程学报 ® 2025 版权所有

通信地址:中国科学院微生物研究所    邮编:100101

电话:010-64807509   E-mail:cjb@im.ac.cn

技术支持:北京勤云科技发展有限公司